Shane Romanchick is a TV and Movie News author for Collider. He also runs his own blog Entershanement Reviews where he writes about and reviews the latest movies. He graduated from Regis College in ...

We've been hearing rumblings that Werewolf by Night will be a departure from the norm for Marvel Studios, and the first trailer and poster for the Halloween special definitely point to it being unlike ...

We got a first look at some footage from Marvel Studios' Werewolf By Night during yesterday's D23 presentation via a bizarre, surprisingly gory trailer, and Disney+ has now debuted some new poster art ...

Howl Movie Poster & Movie Images Have Been Released. We reported on this British horror film a few months ago, when the wonderful trailer and a poster were released. As you could probably tell from ...

Midiankai Runs Down Why He Believes His Artwork is the Original Source of This Image: "I think [Adobe] Illustrator live trace was used on the initial art because it has rounded edges. There are ...

The release of Werewolf by Night is just under three weeks away, and fans of the Marvel Cinematic Universe have never been more excited for the arrival of a D-list Marvel character. Earlier this month ...

"It's hard to say," shared Giacchino in a recent interview when asked if he had a preferred version. "I think the original will always be the original. The vision from the beginning was to do this ...

As we all know, Fantastic Fest is well underway down in Austin, TX. One of the highlight events is a special screening of An American Werewolf in London, with special effects icon Rick Baker, who is ...

Werewolf Therapeutics, Inc., is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer and ...

Chris is a Senior News Writer for Collider. He can be found in an IMAX screen, with his eyes watering and his ears bleeding for his own pleasure. He joined the news team in 2022 and accidentally fell ...

WATERTOWN, Mass., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics ...